Related references
Note: Only part of the references are listed.The effect of peroxisome proliferator-activated receptor-γ Ligands on in vitro and in vivo models of COPD
Simon Lea et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Efficacy and safety of the oral p38 inhibitor PH-797804 in chronic obstructive pulmonary disease: a randomised clinical trial
William MacNee et al.
THORAX (2013)
IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation
T. Southworth et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma
Po-Jui Chang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Restoration of Corticosteroid Sensitivity by p38 Mitogen Activated Protein Kinase Inhibition in Peripheral Blood Mononuclear Cells from Severe Asthma
Nicolas Mercado et al.
PLOS ONE (2012)
Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages
Marianne Jennifer Ratcliffe et al.
BMC PHARMACOLOGY & TOXICOLOGY (2012)
Synergistic Effects of p38 Mitogen-Activated Protein Kinase Inhibition with a Corticosteroid in Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease
J. Armstrong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis
Mark C. Genovese et al.
JOURNAL OF RHEUMATOLOGY (2011)
p38 Mitogen-Activated Protein Kinase-γ Inhibition by Long-Acting β2 Adrenergic Agonists Reversed Steroid Insensitivity in Severe Asthma
Nicholas Mercado et al.
MOLECULAR PHARMACOLOGY (2011)
Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma
P. Bhavsar et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
A Randomized, Placebo-Controlled Study of the Effects of the p38 MAPK Inhibitor SB-681323 on Blood Biomarkers of Inflammation in COPD Patients
Dave Singh et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
A flexible unified approach to the analysis of pre-clinical combination studies
Chris Harbron
STATISTICS IN MEDICINE (2010)
Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages
J. Armstrong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Inhibition of Lipopolysaccharide-Stimulated Chronic Obstructive Pulmonary Disease Macrophage Inflammatory Gene Expression by Dexamethasone and the p38 Mitogen-Activated Protein Kinase Inhibitor N-cyano-N′-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504)
Lauren M. Kent et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Steroid resistance in asthma: Mechanisms and treatment options
Ian M. Adcock et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2008)
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways
Weimin Liu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma
P. Bhavsar et al.
THORAX (2008)
Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma
Mark Hew et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Second-generation inhibitors demonstrate the involvement of p38 mitogen-activated protein kinase in post-transcriptional modulation of inflammatory mediator production in human and rodent airways
MA Birrell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Activation and signaling of the p38 MAP kinase pathway
T Zarubin et al.
CELL RESEARCH (2005)
Mediators of chronic obstructive pulmonary disease
PJ Barnes
PHARMACOLOGICAL REVIEWS (2004)
Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation
M Itoh et al.
MOLECULAR ENDOCRINOLOGY (2002)
p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma
E Irusen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
p38-dependent marking of inflammatory genes for increased NF-kappa B recruitment
S Saccani et al.
NATURE IMMUNOLOGY (2002)
Share Paper
